- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Asp-Leu-
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Asp-Leu-Leu-Pro-Arg-Gly-Ser
| EU orphan designation number: | EU/3/16/1790
|
| Active ingredient: | Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Asp-Leu-Leu-Pro-Arg-Gly-Ser |
| Indication: | Treatment of Huntington’s disease |
| Sponsor: | Dr Ulrich Granzer
Mauerkircherstrasse 105, 81925 München, Deutschland |
Public summary of scientific opinion
European Commission procedures |
CONTACT
EU links
Directorate General Health & Consumers